Amarin Corp Plc (AMRN)

[Pyrrhonian]

I know what it is HD, that doesn’t make it any less available :)

The point is AMRN will never sell V in the EU or Japan. Two vast markets. The other ex-US markets are only going to add minimal profits (some 10% on top of US sales).

Vascepa is in effect a US-only drug. As such, sales estimates are almost entirely restricted to this market.